CVS Health in its registered public offering of $4 billion of senior notes

On August 11, 2025, CVS Health (NYSE: CVS) priced a registered public offering of $4 billion of senior notes, comprised of (i) $750 million aggregate principal amount of its 5.000% Senior Notes due 2032, (ii) $1.5 billion aggregate principal amount of its 5.450% Senior Notes due 2035, (iii) $1.25 billion aggregate principal amount of its 6.200% Senior Notes due 2055 and (iv) $500 million aggregate principal amount of its 6.250% Senior Notes due 2065.

Wachtell, Lipton, Rosen & Katz is serving as legal advisor to CVS Health.